Keywords: neozyme, ii, nabi, cease, hypergam, trial, discontinue

Neozyme II And Nabi To Cease HyperGam+ Trial

Article | 01 July 1996

Print This

- Neozyme II and NABI are to discontinue their Phase II clinical trial for HyperGam+ (immune globulin intravenous) for the treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in